Novo Nordisk says Catalent buyout to close soon as regulatory conditions met

Sedang Trending 1 bulan yang lalu
  • Healthcare
  • M&A

, ,

New Nordisk

hapabapa/iStock Editorial via Getty Images

Novo Nordisk (NVO) announced Saturday that its pending acquisition of 3 Catalent (NYSE:CTLT) accumulation sites is expected to adjacent wrong days arsenic its genitor entity satisfied each regulatory conditions to bargain nan U.S. statement manufacturer.

The announcement followed nan U.S. Federal

Recommended For You

More Trending News

See More »

Selengkapnya
Sumber 1
1